Biotech Hub

Italian researchers find two molecules that can bind to a receptor in human cells and stop SARS-CoV-2 from entering them

The pandemic will not end while vaccine equity keeps getting pushed to the margins.

Large structures can be built from a microbial material with self-healing properties.

The corporate intelligence report provides an all-inclusive overview of multiple inter-related factors that may bring about challenges as well as opportunities for the growth of the Global Gene Editing Tools Market over 2021 to 2027 i.e. the forecast period. It takes into

The Car T Cell Therapy Market is all set to be in the driver’s seat shortly. Technology adoption once looked upon as a costly endeavor, is slated to witness a drastic transformation in the form of granular applications. Technologies like

‘Mad Money’ host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.

After a sharp decline last month, gene editing stocks led by Intellia Therapeutics have recorded double-digit gains today

Browse the archive of articles on Nature Electronics

‘It’s time for these pharmaceutical companies to share their vaccines with the world and start controlling their greed,’ Sanders tweeted.

Austin’s Aeglea BioTherapeutics is hoping to blaze a path reducing a key amino acid biomarker for a rare wasting metabolic disease with its engineered enzyme approach. But with a pivotal outcomes…